Cor Vasa 2019, 61(4):e386-e395 | DOI: 10.33678/cor.2019.036

(Infective endocarditis in a cardiovascular centre with no cardiac surgery unit: epidemiological changes and mortality predictors)

Petr Coufala, Jan Večeřab, Jan Matějkaa, Jiří Vondráka, Martin Kubrychta, Petr Vojtíšeka
a Kardiologické oddělení, Interní klinika, Pardubická nemocnice, Nemocnice Pardubického kraje, a.s., Pardubice
b Pracoviště invazivní arytmologie, Kardiologické centrum Agel a.s., Pardubice

Aim: To evaluate the prognosis and changes in the spectrum of patients with infective endocarditis (IE) in a cardiovascular centre with no cardiac surgery unit and to identify predictors of mortality.

Patients and methods: A retrospective analysis was used to identify 147 patients meeting the Duke criteria for infective endocarditis who were hospitalised in the Cardiology Unit of the Pardubice Regional Hospital from 2000 till 2016. This interval has been divided in two time periods and the profiles of patients in each one were compared. To identify predictors of mortality, we used Cox regression analysis and constructed Kaplan-Meier survival curves.

Results: A total of 84 patients (57%) had native valve endocarditis (NVE), 35 (24%) had prosthetic valve endocarditis (PVE), and 28 (19%) had a cardiac device related infective endocarditis (CDRIE). When comparing the periods 2000-2008 and 2009-2016, there was a 126% increase in the number of infective endocarditis patients, while the average age increased by 4 years. The prevalence of comorbidities and IE predispositions increased as well. We found a relative reduction (27%) in NVE cases and an increase in the number of pa- tients with PVE and CDRIE (9% and 18%, respectively). We did not find any statistically significant difference in endocarditis location, type, or causative microbiological agent. Staphylococci (Staphylococcus aureus + coagulase negative Staphylococci [CoNS]) caused 43% (n = 63) of IE cases, Streptococci caused 18% (n = 26) of cases, and Enterococci 8% (n = 10) of cases. At least one complication was reported in 107 (73%) cases. A combination of antibiotics and surgical therapy was needed in 37% of patients, of whom 63% required urgent surgery. There was a significant increase (16%) in in-hospital mortality. We identified the following as IE mortality predictors: advanced age, heart failure, diabetes mellitus, acute kidney injury, sepsis, perivalvular spread of the infection, multiple-organ failure, and emergency cardio-surgical procedure on circulatory or mechanical ventilation support. We also documented increased mortality in patients with PVE (median survival of 2.9 years)., Conclusion: This retrospective study presents the results of the treatment of patients with infective endocarditis from a cardiology centre with no cardiac surgery unit. Comparing two time periods, 2000-2008 and 2009-2016, we have documented a significant increase in the incidence rate of this disease, especially in PVE and CDRIE, and a relative reduction in NVE. The major etiological cause was Staphylococci. We have also documented significantly increased mortality in patients with PVE and an overall increase in hospital mortality. Univariant analysis has demonstrated the typical predictors of mortality. In addition, comorbidities were also found in NVE only.

Keywords: Endocarditis, Epidemiology, Mortality, Native valve endocarditis, Predictors, Prosthetic valve endocarditis

Published: August 11, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Coufal P, Večeřa J, Matějka J, Vondrák J, Kubrycht M, Vojtíšek P. (Infective endocarditis in a cardiovascular centre with no cardiac surgery unit: epidemiological changes and mortality predictors). Cor Vasa. 2019;61(4):e386-395. doi: 10.33678/cor.2019.036.
Download citation

References

  1. Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75-81. Go to original source... Go to PubMed...
  2. Moreillon P, Que Y-A. Infective endocarditis. Lancet 2004;363:139-149. Go to original source... Go to PubMed...
  3. Mouly S, Ruimy R, Launay O, et al. The changing clinical aspects of infective endocarditis: Descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 2002;45:246-256. Go to original source... Go to PubMed...
  4. Devlin RK, Andrews MM, Von Reyn CF. Recent trends in infective endocarditis: Influence of case definitions. Curr Opin Cardiol 2004;19:134-139. Go to original source... Go to PubMed...
  5. Devlin RK, Andrews MM, Von Reyn CF. Recent trends in infective endocarditis: Influence of case definitions. Curr Opin Cardiol 2004;19:134-139. Go to original source... Go to PubMed...
  6. Mylonakis E, Calderwood SB. Infective Endocarditis in Adults. N Engl J Med 2001;345:1318-1330. Go to original source... Go to PubMed...
  7. Li JS, Sexton DJ, Mick N, et al. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis. Clin Infect Dis 2000;30:633-638. Go to original source... Go to PubMed...
  8. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Infective-Endocarditis-Guidelines-on-Prevention-Diagnosis-and-Treatment-of
  9. Singer M, Deutschman CS, Seymour C, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016;315:801-810. Go to original source... Go to PubMed...
  10. https://www.escardio.org/static_file/Escardio/Subspecialty/EACVI/position-papers/eae-recommendations-mitral-tricuspid-regurgitation.full.pdf
  11. https://www.escardio.org/static_file/Escardio/education/eLearning/webinars/general-cardiology/eae-recommendations-assessment-valvular-regurgitation.pdf
  12. Roudaut R, Barbeau P, Leherissier A, et al. [Diagnostic contribution of transesophageal echocardiography in infectious endocarditis. Apropos of 101 cases]. Arch Mal Coeur Vaiss 1993;86:49-55. Go to PubMed...
  13. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1-138.
  14. Bínová J, Kubánek M, Koudelková E, et al. Changing profile of infective endocarditis in patients hospitalised in a tertiary Czech hospital from 2000 to 2013. Cor Vasa 2016;58:e576-e583. Go to original source...
  15. Hill EE, Herijgers P, Claus P, et al. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2006;28:196-203. Go to original source... Go to PubMed...
  16. Hricak V, Liska B, Kovackova J, et al. Trends in risk factors and etiology of 606 cases of infective endocarditis over 23 years (1984-2006) in Slovakia. J Chemother 2007;19:198-202. Go to original source... Go to PubMed...
  17. Marks DJB, Hyams C, Koo CY, et al. Clinical features, microbiology and surgical outcomes of infective endocarditis: A 13-year study from a UK tertiary cardiothoracic referral centre. QJM 2015;108:219-229. Go to original source... Go to PubMed...
  18. Wallace SM, Walton BI, Kharbanda RK, et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002;88:53-60. Go to original source... Go to PubMed...
  19. Murdoch DR, Corey RG, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century The international collaboration on Endocarditis- -prospective cohort study. Arch Intern Med 2009;169:463-473. Go to original source... Go to PubMed...
  20. Nadji G, Rusinaru D, Rémadi JP, et al. Heart failure in left-sided native valve infective endocarditis: Characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail 2009;11:668-675. Go to original source... Go to PubMed...
  21. Hill EE, Herregods M-C, Vanderschueren S, et al. Outcome of patients requiring valve surgery during active infective endocarditis. Ann Thorac Surg 2008;85:1564-1569. Go to original source... Go to PubMed...
  22. Bor DH, Woolhandler S, Nardin R, et al. Infective Endocarditis in the U.S., 1998-2009: A Nationwide Study. PLoS One 2013;8:e60033. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.